Filing Details
- Accession Number:
- 0002001011-24-000028
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-29 18:50:28
- Reporting Period:
- 2024-02-27
- Accepted Time:
- 2024-02-29 18:50:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 886163 | Ligand Pharmaceuticals Inc | LGND | Pharmaceutical Preparations (2834) | 770160744 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1905248 | Octavio Espinoza | 3911 Sorrento Valley, Suite 110 San Diego CA 92121 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-02-27 | 7,208 | $0.00 | 28,631 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2024-02-28 | 799 | $55.75 | 29,430 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-02-28 | 140 | $57.22 | 29,570 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-02-28 | 325 | $58.49 | 29,895 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-28 | 140 | $88.46 | 29,755 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2024-02-28 | 799 | $0.00 | 799 | $55.75 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2024-02-28 | 140 | $0.00 | 140 | $57.22 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2024-02-28 | 325 | $0.00 | 325 | $58.49 |
| Common Stock | Employee Stock Option (right to buy) | Acquisiton | 2024-02-27 | 29,272 | $0.00 | 29,272 | $89.20 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,869 | 2030-02-13 | No | 4 | M | Direct | |
| 7,722 | 2030-10-01 | No | 4 | M | Direct | |
| 1,607 | 2027-02-24 | No | 4 | M | Direct | |
| 29,272 | 2034-02-27 | No | 4 | A | Direct |
Footnotes
- Represents Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest over three years, in three substantially equal annual installments on February 15, 2025; February 15, 2026; and February 15, 2027, subject to the Reporting Person's continued service to the Issuer through each such vesting date.
- As per the separation of OmniAb Inc. from the issuer, 2,039 stock options were vested and exercisable as of November 1, 2022, whereas 1,629 options vest in 16 substantially equal monthly installments beginning on November 13, 2022.
- As per the separation of OmniAb Inc. from the issuer, 4,096 stock options were vested and exercisable as of November 1, 2022, whereas 3,766 options vest in 23 substantially equal monthly installments beginning on December 1, 2022.
- The stock option is fully vested and exercisable.
- The Stock Option grant vests and is exercisable as to 12.5% of the underlying shares 6 months after the grant date, and in 42 substantially equal monthly installments thereafter.
Billionaire Hedge Funds
